NDC 68682-464
BRINZOLAMIDE
Brinzolamide
BRINZOLAMIDE is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Oceanside Pharmaceuticals.. The primary component is Brinzolamide.
| Product ID | 68682-464_fb7229d4-522e-4cb2-b513-9d34f3ded591 |
| NDC | 68682-464 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BRINZOLAMIDE |
| Generic Name | Brinzolamide |
| Dosage Form | Suspension/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2021-08-25 |
| Marketing Category | ANDA / |
| Application Number | ANDA204884 |
| Labeler Name | Oceanside Pharmaceuticals. |
| Substance Name | BRINZOLAMIDE |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |